THE RESTORATION OF HYPOTHALAMIC SIGNALING SYSTEMS AS ONE OF THE CAUSES TO IMPROVE THE METABOLIC PARAMETERS IN BROMOCRYPTINE-TREATED RATS WITH NEONATAL MODEL OF DIABETES MELLITUS

One of the approaches to correct type 2 diabetes mellitus (T2DM) and its complications is the use of drug bromocryptine mesylate (BCM), a selective agonist of type 2 dopamine receptors (DA2R). At the same time, the efficiency and the mechanisms of action of BCM in treatment of severe forms of T2DM a...

Celý popis

Podrobná bibliografia

Vydané v:	T͡S︡itologii͡a Ročník 59; číslo 2; s. 140
Hlavní autori:	Derkach, K V, Ivantsov, A O, Sukhov, I B, Shpakov, A O
Médium:	Journal Article
Jazyk:	English Russian
Vydavateľské údaje:	Russia (Federation) 2017
ISSN:	0041-3771
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!